Filippo Stragliati

Ergründung schlafbezogener Atmungsstörungen bei amyotropher Lateralsklerose: Über den Apnoe-Hypopnoe-Index und die schlafbezogene Hypoxie hinaus

Andi Nuredini, Dario Bottignole, Filippo Stragliati, Pietro Anceschi et autres

Die rechtzeitige Integration der nicht invasiven Beatmung (non-invasive ventilation, NIV) im Rahmen der multidisziplinären Behandlung von Patienten mit amyotropher Lateralsklerose (ALS) ist von besonderer Relevanz und stützt sich auf die korrekte Identifizierung von Warnsignalen im Hinblick auf eine Erschöpfung des Zwerchfells. Die …

it, us (code pays fourni par la source)

Unraveling sleep respiratory dysfunction in amyotrophic lateral sclerosis: Beyond the apnea-hypopnea index and sleep-related hypoxia

Andi Nuredini, Dario Bottignole, Filippo Stragliati, Pietro Anceschi et autres

The timely introduction of non-invasive ventilation (NIV) is extremely relevant in the multidisciplinary management of patients affected by amyotrophic lateral sclerosis (ALS) and is based on the proper identification of red flags for early diaphragmatic exhaustion. Polygraphic sleep recording may provide insightful …

it (code pays fourni par la source)

Unraveling Sleep Respiratory Dysfunction in Amyotrophic Lateral Sclerosis: Beyond the Apnea-Hypopnea Index and Sleep-Related Hypoxia

Andi Nuredini, Dario Bottignole, Filippo Stragliati, Pietro Anceschi et autres

it (code pays fourni par la source)

Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study

Elisabetta Zucchi, Umberto M. Musazzi, Guido Fedele, Ilaria Martinelli et autres

Background: Oral tauroursodeoxycholic acid (TUDCA) is a commercial drug currently tested in patients with amyotrophic lateral sclerosis (ALS) both singly and combined with sodium phenylbutyrate. This retrospective study aimed to investigate, in a real-world setting, whether TUDCA had an impact on the …

it (code pays fourni par la source)

Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study

Giulia Gianferrari, Ilaria Martinelli, Cecilia Simonini, Elisabetta Zucchi et autres

Few studies have focused on elderly (>80 years) amyotrophic lateral sclerosis (ALS) patients, who represent a fragile subgroup generally not included in clinical trials and often neglected because they are more difficult to diagnose and manage. We analyzed the clinical and genetic …

it, us (code pays fourni par la source)